Spinocerebellar ataxia type 6 (SCA6) is an inherited ataxia which presently has no cure (Solodkin and Gomez, 2012). It is caused by a CAG expansion mutation that generates an expanded polyglutamine tract in the translated protein (Zhuchenko et al., 1997). The affected gene is CACNA1A (Zhuchenko et al., 1997), which encodes both the alpha subunit of voltage-gated calcium P/Q channels and a putative transcription factor (Du et al., 2019; Du et al., 2013). The cellular dysfunction giving rise to disease in SCA6 is poorly understood. Here, we examine the role of the endo-lysosomal system in SCA6 pathophysiology.

The endo-lysosomal system comprises of a series of membrane-bound compartments that sort and transport endocytosed molecules destined for recycling or degradation (Figure 1a; Hu et al., 2015; Huotari and Helenius, 2011). These compartments are highly dynamic and regularly interact and fuse with each other as cargo is sorted and trafficked. Each compartment has a characteristic pH mediated by ATP-dependent acidification (Hu et al., 2015), and is characterized by the presence of specific proteins that allow them to carry out their functions. Rab GTPases regulate trafficking of cargo, and each compartment is associated with a specific signature of Rab family members (Stenmark, 2009). Endocytosed cargo arrives first at the early endosomes (Ludwig et al., 1991), where the slightly acidic pH leads to dissociation of ligands from their receptors. Here, the cargo will undergo sorting: those that are destined for recycling such as receptors, will be returned to the cell surface. Cargo that is destined for further sorting or degradation will move to the late endosomes, which are characterized by an increasingly acidic pH and increased enzymatic activity (Hu et al., 2015; Huotari and Helenius, 2011). The lysosome is the final destination of cargo that is to be degraded. This compartment is the most acidic and contains over 50 hydrolases that carry out rapid degradation of cargo (de Duve, 2005; Lawrence and Zoncu, 2019).

Figure 1

Download asset Open asset

Figure 1—source data 1

Normalized reads of endolysosomal genes.

https://cdn.elifesciences.org/articles/90510/elife-90510-fig1-data1-v1.xlsx

Download elife-90510-fig1-data1-v1.xlsx

Endosome dysfunction plays a role in the pathophysiology of several neurological diseases. A notable example is Alzheimer’s disease, where postmortem brain tissue from patients displays increased early endosome size and accumulation of cargo (Cataldo et al., 2004; Cataldo et al., 2000; Cataldo et al., 1997; Tate and Mathews, 2006). Similar early endosome changes are seen in Down syndrome (Cataldo et al., 2000) and Niemann Pick C (Jin et al., 2004; Kim et al., 2023). In the cerebellum, endo-lysosomal dysfunction can lead to cerebellar dysfunction (Akizu et al., 2015; Mannan et al., 2004; Sterling et al., 2023; Vanier, 2010), and has been identified in cerebellar diseases with diverse disease-causing mechanisms (Alves et al., 2014; Zhu et al., 2022). As endosomes are the site of disassociation of ligands from their receptors, mediating both the recycling of receptors back to the cell surface and the sorting of ligands for further signaling or degradation, dysfunction can disrupt signaling pathways due to mis-trafficking of signaling molecules.

Previously, lysosomal accumulation of protein aggregates has been observed in a mouse model of SCA6 (118Q) that features a hyperexpanded polyglutamine repeat (Unno et al., 2012). This suggests that lysosomes may play a role in SCA6. Cerebellar pathology in this model was worsened when lysosomal function was impaired by the loss of the lysosomal enzyme cathepsin B (Unno et al., 2012). However, it has been unknown whether endo-lysosomal pathway dysregulation is implicated in the natural disease progression of SCA6, or whether other endosomal compartments may be involved.

We have recently found that deficits in the brain-derived neurotrophic factor (BDNF)–tropomyosin kinase B (TrkB)–Akt signaling pathway contribute to SCA6 pathophysiology (Cook et al., 2022), with both BDNF and TrkB expression reduced in the cerebellar vermis. However, the underlying causes of the reduced levels of BDNF and TrkB remained unknown. Since both BDNF and TrkB are dynamically trafficked through the endo-lysosomal system (Moya-Alvarado et al., 2023; Moya-Alvarado et al., 2018; Yamashita and Kuruvilla, 2016), we wondered whether dysfunction in this system could underlie BDNF and/or TrkB mislocalization, contributing to subsequent cellular dysfunction in SCA6.

To address whether alterations in the endo-lysosomal system give rise to cellular dysfunction in SCA6, we examined endo-lysosomal compartments in the cerebellum of male and female SCA6^84Q/84Q mice (referred to as SCA6 mice) in the early stages of SCA6 progression. In addition to observing abnormalities in endosomal compartments, we found that BDNF and its receptor TrkB accumulated in early endosomes instead of undergoing normal sorting and recycling. These abnormalities were present in SCA6 mice between 7 and 12 months of age, coincident with the onset of motor impairment and long before Purkinje cell degeneration (Jayabal et al., 2015). These changes therefore represent an early driver of SCA6 pathology. We were able to rescue the deficits in early endosomes with chronic administration of the TrkB agonist 7,8-dihydroxyflavone (7,8-DHF), a treatment that we previously found could also rescue behavioral and Purkinje cell firing deficits in the SCA6 mice. Our findings argue that endo-lysosomal dysfunction is a novel locus of pathophysiology in spinocerebellar ataxia and a potential therapeutic target to investigate further.

The endo-lysosomal system (Figure 1a) is critical for proper cellular function and its dysregulation is associated with mis-trafficking of important cargo. Here, we address whether endo-lysosomal dysfunction contributes to SCA6, using a mouse model (SCA6^84Q/84Q mice, referred to as SCA6 mice) that robustly models the mid-life onset of motor deficits and cerebellar dysfunction seen in SCA6 patients (Jayabal et al., 2015; Watase et al., 2008). We have previously shown that around 7 months of age, SCA6 mice develop deficits in motor coordination that progressively worsen (Jayabal et al., 2015; Jayabal et al., 2016) and display cellular deficits, including aberrant Purkinje cell firing and disrupted BDNF–TrkB signaling (Cook et al., 2022; Chang et al., 2022; Jayabal et al., 2016). The cellular alterations that lead to the reduction of BDNF and TrkB in the SCA6 cerebellum remained unknown, so we conducted further investigation into potential causes.

We carried out RNA-sequencing on cerebellar vermis tissue from 12-month-old litter-matched wildtype (WT) and SCA6 mice (N = 5 for each genotype) during the course of another investigation. This sequencing revealed that many genes involved in the endo-lysosomal system, as defined by the gene ontology (GO:CC) terms ‘Endosome’ (GO:0005768) and ‘Lysosome’ (GO:0005764), were significantly dysregulated in the SCA6 cerebellum (Figure 1b, p_adj < 0.05, see Table 1 for a full list). The expression levels of these genes were altered by between 10% and 200% in SCA6 compared to WT. Endosomal genes were found to be both up- and downregulated in SCA6, but the genes covered by the Lysosome GO term were mostly upregulated compared to WT. The affected genes are associated with multiple endosomal compartments, meaning that the cellular consequences could be wide reaching. We therefore aimed to determine whether different compartments of the endo-lysosomal system (Figure 1a) are altered in the cerebellum of SCA6 mice, and whether this could contribute to previously described BDNF and TrkB deficits, via mis-trafficking through the endo-lysosomal system.

Early endosomes are enlarged and accumulate BDNF and TrkB in Purkinje cells in SCA6 mice

Early endosomes are the first stop for newly endocytosed cargo. There, cargo undergoes sorting as the slightly acidic pH facilitates ligand release from receptors (Figure 2a). We carried out immunohistochemistry (IHC) against early endosome antigen 1 (EEA1) on sections of cerebellar vermis from 7- to 8-month WT and SCA6 mice and found that EEA1 staining is present in the cerebellum, particularly in Purkinje cells (Figure 2b). We imaged Purkinje cells and could identify large tubular early endosomes in Purkinje cell somas of both WT and SCA6 mice (Figure 2b, c). The early endosome marker in SCA6 Purkinje cells covered a larger area, showing that the early endosome compartment is enlarged in SCA6 (Figure 2c,d). A similar enlargement of early endosomes has been seen in other neurological diseases (Cataldo et al., 2000; Cataldo et al., 1997; Jin et al., 2004). Using the EEA1 marker to delineate early endosomes, we were able to analyze BDNF and TrkB localized within the early endosome compartment. There was a higher amount of BDNF staining within the early endosomes of Purkinje cells from SCA6 mice (Figure 2e, f). This was intriguing as we have previously shown that BDNF levels in the cerebellar vermis as a whole are decreased (Cook et al., 2022), so BDNF accumulates specifically in this compartment despite depressed levels overall in the cerebellum. We found the same was true for TrkB, as TrkB immunoreactivity was increased within the EEA1-positive early endosome compartment in SCA6 Purkinje cells compared to WT (Figure 2g, h). Nearly all of the TrkB staining within SCA6 Purkinje cells colocalized with the EEA1 marker (Figure 2g, arrowheads), whereas the tissue from WT mice showed abundant TrkB staining outside the early endosome compartment of Purkinje cells (Figure 2g, arrowheads). Thus, early endosomes are enlarged and accumulate BDNF and TrkB in SCA6, despite decreased levels of both proteins in the SCA6 cerebellum as a whole. This cargo mis-trafficking could lead to a decrease in the amount of free BDNF available to signal, as well as the amount of TrkB recycled to the cell surface, thereby contributing to previously described BDNF–TrkB signaling deficits in SCA6 (Cook et al., 2022).

Figure 2

Download asset Open asset

Recycling endosomes are morphologically normal in SCA6

Since we identified an accumulation of TrkB in early endosomes, we wondered whether this would affect the amount of TrkB recycled back to the cell surface. Recycling endosomes return receptors to the plasma membrane for further signaling (Figure 3a; O’Sullivan and Lindsay, 2020). Syntaxin 12/13 (Stx13) is involved in recycling of endocytosed proteins back to the plasma membrane and is located in recycling endosomes and some tubular protrusions from early endosomes that are also involved in recycling (Prekeris et al., 1998). We used two different antibodies for Stx13 as a marker for the recycling endosome compartment. Staining with both antibodies revealed a large network of small recycling endosomes and protrusions in Purkinje cells (Figure 3b, Figure 3—figure supplement 1). Analysis of the staining with both antibodies showed that recycling endosome area was unchanged in SCA6 Purkinje cells (Figure 3c, Figure 3—figure supplement 1). We noted colocalization between TrkB and Stx13, showing TrkB being recycled back to the cell surface after dissociation from bound BDNF in the early endosomes. The TrkB staining within the recycling endosome compartment marked by Stx13 was decreased in Purkinje cells in SCA6 mice (Figure 3d). Combined with the increased levels of TrkB in the early endosomes of Purkinje cells in SCA6 (Figure 2h), these data argue that TrkB is stuck in early endosomes in SCA6, rather than being recycled to the cell surface to the same extent as in WT Purkinje cells. This mislocalization may contribute to the depressed levels of BDNF–TrkB signaling previously described in SCA6 (Cook et al., 2022).

Figure 3 with 1 supplement see all

Download asset Open asset

Late endosomes

Early endosomes undergo maturation into late endosomes in order to transport cargo destined for degradation to the lysosomes (Huotari and Helenius, 2011; Figure 4a). Neurons use this degradative pathway as a way to regulate BDNF levels (Evans et al., 2011). We used Rab7 as a marker for late endosomes (Vitelli et al., 1997), and identified numerous late endosomes in Purkinje cells of both WT and SCA6 mice (Figure 4b). The Rab7 staining covered a smaller area in the Purkinje cells of SCA6 mice compared to WT (Figure 4c), indicating a reduction in the size or number of late endosomes. Most of the BDNF staining within the Purkinje cells did not colocalize with Rab7 (Figure 4b), which was expected as we had previously found high levels of colocalization of BDNF with the early endosome marker EEA1 (Figure 2e). The BDNF staining that was present within the Rab7-positive late endosome compartment was significantly reduced in SCA6 compared to WT (Figure 4d), suggesting that BDNF accumulates in the early endosomes earlier in the endosomal pathway (Figure 2f), preventing its progression through the late endosomal stage. Late endosomes transport cargo to lysosomes for degradation, so less BDNF may reach the lysosome in SCA6. This could have implications for the regulation of BDNF within Purkinje cells, as neurons tightly regulate BDNF levels via degradative pathways (Evans et al., 2011).

Figure 4

Download asset Open asset

Lysosomal morphology is unchanged in SCA6

We next aimed to determine whether lysosomes were altered in SCA6, using a dual strategy to visualize the lysosomes in cerebellar slices. We first used a pH-sensitive dye, LysoTracker Red DND 99, to visualize the acidic lysosomes (Figure 5a, b; Chazotte, 2011). As LysoTracker labels all acidic compartments, it is not sufficient to confirm the identity of lysosomes. This may be particularly problematic if other intracellular compartments undergo inappropriate acidification, which has been observed in other neurological diseases (Pescosolido et al., 2021). Therefore, after staining acute cerebellar slices with LysoTracker, we performed IHC for Lysosomal-associated membrane protein 1 (Lamp1), a glycoprotein localized at the membranes of lysosomes. Because even Lamp1 can be localized outside of lysosomes (Cheng et al., 2018), we used both LysoTracker and Lamp1 to identify lysosomes in Purkinje cells. We found that both stains labelled lysosomes within Purkinje cells (Figure 5b). As expected, the Lamp1 staining appeared as ring-like structures, marking the membranes of the lysosomes, while LysoTracker staining marked the acidic lumen of the lysosomes, in the center of these rings (Figure 5b, see zoom). While Lamp1 staining identified a large number of lysosomes of varying size, the LysoTracker stain was present only in the largest. This discrepancy has been noted previously, as LysoTracker does not label the smallest lysosomes in cerebellar slices or other cell preparations that are fixed after staining (Chazotte, 2011; Song et al., 2008). We found that the total area covered by the Lamp1 and LysoTracker stains was not significantly different between Purkinje cells from WT and SCA6 mice (Figure 5c, d). The area of colocalization between the two stains was also unchanged (Figure 5e).

Figure 5 with 1 supplement see all

Download asset Open asset

To investigate further and determine whether the two stains label the same population of lysosomes in the two genotypes, we counted the number of lysosomes labeled by different combinations of the two markers. The lysosomes labeled by these two strategies could be divided into three groups. (1) Compartments stained by both Lamp1 and LysoTracker, confirming that they are indeed lysosomes. The number of these lysosomes was indistinguishable between WT and SCA6 mice (Figure 5f), indicating that Lamp1-positive lysosomes are present in normal quantities and are appropriately acidified in SCA6 Purkinje cells. In agreement, the area covered by each stain per lysosome, a proxy for the size of the lysosomes, was unchanged in SCA6 (Figure 5—figure supplement 1). (2) Lysosomes labeled by Lamp1 but not LysoTracker (Figure 5g) represent small lysosomes unable to retain the LysoTracker dye after fixation (Chazotte, 2011; Song et al., 2008). This number was not significantly different between WT and SCA6 mice and so Lamp1 appears to be present at normal levels and is appropriately localized to lysosomes in SCA6. (3) Organelles labeled by LysoTracker but not Lamp1 could include maturing late endosomes or other endosomal compartments that are inappropriately acidified. Late endosomes have an acidic pH and Rab7-positive late endosomes can be LysoTracker positive (Majzoub et al., 2016). Late endosomes fuse with lysosomes to complete cargo degradation, but first they mature into an intermediate compartment called an endolysosome (Huotari and Helenius, 2011). Therefore, these LysoTracker-positive Lamp1-negative organelles could be late endosomes or intermediate endolysosomes that have not yet fused with the Lamp1-positive lysosomes. The number of these compartments was low in Purkinje cells in both genotypes but was significantly lower in SCA6 mice (Figure 5h). This agrees with our finding of a reduction in the size of the late endosome compartment in SCA6 mice (Figure 4c). A reduction in the late endosome compartment suggests that there are fewer late endosomes available to mature and fuse with lysosomes. Therefore, the Lamp1-positive lysosomes are morphologically normal in the Purkinje cells of SCA6 mice while the small alteration in Lysotracker staining likely represents a deficit in the maturation of late endosomes before fusion with lysosomes.

Taken together, these results suggest that although lysosomes are present in normal numbers, the trafficking of endocytosed cargo to the lysosome for degradation is impaired in the SCA6 cerebellum. Our transcriptomic data furthermore show that genes encoding lysosomal proteins are abnormally expressed in SCA6 (Figure 1b), suggesting that lysosomal dysfunction is present in SCA6. Lysosomes are enzymatically active sites of degradation and contain multiple proteases that rapidly break down proteins. However, lysosomal proteolysis depends not just on enzymatic activity, but on the correct transport of proteins to the lysosomes through endosomal compartments. We wondered whether the deficits we identified in early and late endosomes (Figures 2 and 4), or other deficits in lysosome activity, might impair the ability of lysosomes to degrade endocytosed cargo in SCA6. We assayed this by incubating acute cerebellar slices with BODIPY FL Pepstatin A, an exogenous peptide that can be endocytosed and transported to the lysosome, where it binds to the active form of the lysosomal enzyme Cathepsin D (Chen et al., 2000; Figure 6a). We could visualize Pepstatin A signal within Lamp1-positive puncta, demonstrating Cathepsin D enzymatic activity within lysosomes (Figure 6b). The Pepstatin A signal within Purkinje cells was significantly reduced in SCA6 mice (Figure 6c, d), revealing a lower level of either the endocytosed construct, or of active Cathepsin D. The identification of alterations in the early and late endosomes that transport cargo to the lysosomes (Figures 2 and 4), suggests that SCA6 Purkinje cells have endosomal deficits that reduce transport of the endocytosed Pepstatin A construct to the lysosome where it can bind active Cathepsin D. This finding is therefore consistent with an overall impairment of endo-lysosomal trafficking. The reduction in Pepstatin A signal would also be consistent with a reduction in Cathepsin D enzymatic activity that could further contribute to aberrant handling of endocytosed cargo in SCA6. RNA-sequencing identified an upregulation of lysosomal enzyme transcripts in the SCA6 cerebellum, including the CTSD gene encoding Cathepsin D (Figure 1b). However, this would not necessarily lead to an increase in enzyme activity as the RNA must first be translated, and then undergo post-translational proteolytic processing in order to produce the active form of Cathepsin D that binds Pepstatin A (Zaidi et al., 2008). This suggests that in SCA6, there is an upregulation in CTSD and other lysosomal genes that does not lead to an increase in functional enzymes. This may be a compensatory mechanism for trafficking deficits of cargoes to the lysosomal compartment, or an attempt to compensate for deficits in the production of the active form of Cathepsin D. In summary, our results illustrate that Purkinje cells in SCA6 mice have an impaired ability to degrade other endocytosed cargo beyond BDNF and TrkB. This likely arises from trafficking deficits that result in a disruption in the transport of cargo to the lysosomes, along with lysosomal dysfunction.

Figure 6

Download asset Open asset

7,8-DHF rescues deficits in early endosomes

We have previously shown that the putative TrkB agonist 7,8-DHF increases TrkB expression and activates Akt signaling downstream of TrkB, leading to a rescue of deficits in motor coordination and Purkinje cell firing in SCA6 mice (Figure 7a; Cook et al., 2022). One interpretation of this rescue is that the TrkB agonist compensates for reduced levels of BDNF in the SCA6 cerebellum, thereby activating downstream signaling cascades to restore cerebellar function. However, we have also previously shown that TrkB activation with 7,8-DHF led to increased levels of TrkB in the SCA6 cerebellum (Cook et al., 2022), suggesting that self-amplification of TrkB signaling may play a role in the rescue. 7,8-DHF may therefore not be simply replacing lost BDNF in SCA6. Indeed, there is some evidence that 7,8-DHF may act via antioxidant or anti-inflammatory effects independent of TrkB activation (Chen et al., 2011; Han et al., 2014; Park et al., 2012). Given that TrkB signaling is known to be involved in the regulation and trafficking of endosomes (Scott-Solomon and Kuruvilla, 2018), we wondered whether chronic oral administration of 7,8-DHF to SCA6 mice would rescue the deficits in early endosome size, either due to TrkB activation or another mechanism of action. We used the same treatment regimen of 7,8-DHF that had previously been shown to rescue deficits in behavior and Purkinje cell firing, which comprised of 1 month of oral administration of the drug to peri-onset (6- to 7-month-old) SCA6 mice (Figure 7a). Half of the mice received control solution with no drug added. After 1 month of 7,8-DHF administration, cerebellar vermis sections were stained for BDNF and EEA1 as an early endosome marker, as previously described (Figure 2). 7,8-DHF administration rescued the size of the early endosomes, with the total EEA1 area within Purkinje cells reducing to the WT level previously described (Figure 7b, c). The level of BDNF accumulation within the early endosomes was also restored (Figure 7d), suggesting that in addition to self-amplifying upregulation of TrkB (Cook et al., 2022), treatment with 7,8-DHF can normalize intracellular localization and trafficking of BDNF, consistent with the role of TrkB in regulating endosome trafficking and function (Scott-Solomon and Kuruvilla, 2018).

Figure 7

Download asset Open asset

We have identified multiple novel deficits in the endo-lysosomal pathway that could contribute to BDNF–TrkB signaling alterations in SCA6 (Figure 8). Early endosomes were enlarged in SCA6 and accumulate BDNF and TrkB. Recycling endosomes were morphologically normal but carried less TrkB, and late endosomes were reduced in size and carried less BDNF. This suggests that cargo is getting stuck in the enlarged early endosomes in SCA6. The involvement of lysosomal pathology in SCA6 is less clear. Lysosomes appear morphologically normal with normal pH, but RNA-sequencing revealed upregulation of lysosomal genes in SCA6. SCA6 Purkinje cells also showed a reduction in exogenous cargo binding to the lysosomal enzyme Cathepsin D, indicating either a deficit in lysosomal enzyme activity, defects in endocytosis and cargo trafficking to lysosomes, or both. Taken together, these deficits could lead to cellular dysfunction in SCA6. This work further highlights how BDNF and TrkB deficits manifest in SCA6, and the potential of targeting this pathway therapeutically.

Figure 8

Download asset Open asset

Excitingly, both the enlargement of early endosomes and the accumulation of BDNF in early endosomes could be rescued by the putative TrkB agonist, 7,8-DHF. There is evidence that TrkB can regulate its own expression and signaling (Cheng et al., 2011; Haapasalo et al., 2002) and we had previously shown that 7,8-DHF administration increased levels of TrkB in the cerebellum of SCA6 mice (Cook et al., 2022). This new finding demonstrates that not only does 7,8-DHF regulate the expression of TrkB in the SCA6 cerebellum, but also the localization of the ligand for TrkB within endosomal compartments, providing insight into the mechanisms by which BDNF and TrkB are regulated in the cerebellum. Furthermore, the finding that 7,8-DHF can rescue endosomal deficits in SCA6 supports the promise of 7,8-DHF and related molecules as potential therapeutics for SCA6 and raises the possibility of their use for treatment of other disorders displaying early endosome deficits.

Early endosome deficits are not unique to SCA6, meaning that this finding may have a wider application. Enlargement of early endosomes is a hallmark of dysfunction in the endosomal pathway (Kaur et al., 2018) and has been observed in multiple diseases including Alzheimer’s disease (Cataldo et al., 2004; Cataldo et al., 2000; Cataldo et al., 1997; Tate and Mathews, 2006), Down syndrome (Cataldo et al., 2000), models of macular degeneration (Kaur et al., 2018), Charcot–Marie–Tooth (Bucci et al., 2012), and Parkinson’s disease (Vidyadhara et al., 2019). Early endosome abnormalities can arise from deficits in maturation or fusion of early endosomes, or alterations in the microtubule networks that govern endosome fusion (Skjeldal et al., 2012). Purkinje cells may be particularly susceptible to early endosome enlargement, as in postmortem tissue from Niemann Pick type C patients, Purkinje cells had enlarged early endosomes which accumulated amyloid precursor protein, whereas in the hippocampus, pathology mostly concerned late endosomes (Jin et al., 2004). However, endosomal pathology in SCA6 and other diseases is not limited to early endosomes, and other endosomal compartments can be targeted therapeutically (Bonam et al., 2019; Tate and Mathews, 2006). In addition to identifying TrkB activation as a therapeutic strategy for endosome deficits, our work opens the door for the development of additional endosome-targeting treatment strategies for SCA6.

Our findings provide the first evidence for endosomal dysfunction contributing to signaling deficits in spinocerebellar ataxias. Other ataxias like SCA1 also have reduced BDNF protein levels (Mellesmoen et al., 2018), so it would be interesting to determine whether early endosome deficits could contribute to disrupted BDNF signaling in other ataxias. Polyglutamine diseases in general are thought to have disruption in protein degradation pathways (Chai et al., 1999; Cortes and La Spada, 2015), and SCA7 patients and mouse models display alterations in lysosome pathways (Alves et al., 2014). Therefore, similar abnormalities could be a common feature of similar diseases.

There remain, however, some unanswered questions from our study. What is the specific deficit that leads to early endosome enlargement and other deficits? Is it the same as in other neurological diseases? Future work to identify this will further aid in the development of endosome-targeting therapies. There is also the question of the effect on other cargo. Sorting and recycling happens in a cargo-specific manner (Hu et al., 2015) and so other cargo could be handled differently. Here, we investigated endosomal trafficking of BDNF and TrkB as we have previously shown this pathway to be both dysregulated in SCA6, and amenable to therapeutic targeting. However, our experiments with BODIPY FL Pepstatin A suggest that even exogenous cargo could be transported differently in SCA6. Future research should consider whether other cargo accumulate in early endosomes and how this affects cell physiology. Furthermore, in parallel to endocytosis and endosome trafficking, cells transport proteins for degradation in lysosomes via autophagy (Klionsky, 2005). There are therefore two pathways with a common destination of degradation in lysosomes, both of which are important for cell function, and abnormalities in one pathway can lead to disruption in the other (Birgisdottir and Johansen, 2020; Mahapatra et al., 2019). Future work should therefore investigate whether autophagy is disrupted in SCA6. Finally, while most of our study was conducted around disease onset, the transcriptomic alterations were measured at a later timepoint, which raises the question of whether transcriptional changes drive endo-lysosomal alterations or are in fact a result of endo-lysosomal changes that are caused by a different mechanism. A careful study of the timeline of these changes will help us understand the sequence of events as disease progresses in SCA6.

In summary, we have identified a dysregulated cellular trafficking pathway that contributes to cerebellar pathophysiology that is novel not just in SCA6, but in SCAs in general. We found that several components of the endo-lysosomal system show abnormalities in Purkinje cells in SCA6 mice. These deficits could contribute to BDNF–TrkB signaling deficits in SCA6, as BDNF and TrkB accumulate in early endosomes and there is a reduction in TrkB being recycled to the cell membrane for further signal transduction. The endo-lysosomal system is therefore a promising therapeutic target for SCA6.

Source data files have been provided for Figure 1.

1. 1. Akizu N
   2. Cantagrel V
   3. Zaki MS
   4. Al-Gazali L
   5. Wang X
   6. Rosti RO
   7. Dikoglu E
   8. Gelot AB
   9. Rosti B
   10. Vaux KK
   11. Scott EM
   12. Silhavy JL
   13. Schroth J
   14. Copeland B
   15. Schaffer AE
   16. Gordts P
   17. Esko JD
   18. Buschman MD
   19. Field SJ
   20. Napolitano G
   21. Abdel-Salam GM
   22. Ozgul RK
   23. Sagıroglu MS
   24. Azam M
   25. Ismail S
   26. Aglan M
   27. Selim L
   28. Mahmoud IG
   29. Abdel-Hadi S
   30. Badawy AE
   31. Sadek AA
   32. Mojahedi F
   33. Kayserili H
   34. Masri A
   35. Bastaki L
   36. Temtamy S
   37. Müller U
   38. Desguerre I
   39. Casanova JL
   40. Dursun A
   41. Gunel M
   42. Gabriel SB
   43. de Lonlay P
   44. Gleeson JG

   (2015) Biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy and lysosome-autophagosome dysfunction

   Nature Genetics 47:528–534.

   https://doi.org/10.1038/ng.3256

   • PubMed
   • Google Scholar
2. 1. Alves S
   2. Cormier-Dequaire F
   3. Marinello M
   4. Marais T
   5. Muriel MP
   6. Beaumatin F
   7. Charbonnier-Beaupel F
   8. Tahiri K
   9. Seilhean D
   10. El Hachimi K
   11. Ruberg M
   12. Stevanin G
   13. Barkats M
   14. den Dunnen W
   15. Priault M
   16. Brice A
   17. Durr A
   18. Corvol JC
   19. Sittler A

   (2014) The autophagy/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice

   Acta Neuropathologica 128:705–722.

   https://doi.org/10.1007/s00401-014-1289-8

   • PubMed
   • Google Scholar
3. 1. Anders S
   2. Pyl PT
   3. Huber W

   (2015) HTSeq--a Python framework to work with high-throughput sequencing data

   Bioinformatics 31:166–169.

   https://doi.org/10.1093/bioinformatics/btu638

   • PubMed
   • Google Scholar
4. 1. Birgisdottir ÅB
   2. Johansen T

   (2020) Autophagy and endocytosis - interconnections and interdependencies

   Journal of Cell Science 133:jcs228114.

   https://doi.org/10.1242/jcs.228114

   • PubMed
   • Google Scholar
5. 1. Bonam SR
   2. Wang F
   3. Muller S

   (2019) Lysosomes as a therapeutic target

   Nature Reviews. Drug Discovery 18:923–948.

   https://doi.org/10.1038/s41573-019-0036-1

   • PubMed
   • Google Scholar
6. 1. Bucci C
   2. Bakke O
   3. Progida C

   (2012) Charcot-Marie-Tooth disease and intracellular traffic

   Progress in Neurobiology 99:191–225.

   https://doi.org/10.1016/j.pneurobio.2012.03.003

   • PubMed
   • Google Scholar
7. 1. Cataldo AM
   2. Barnett JL
   3. Pieroni C
   4. Nixon RA

   (1997) Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer’s disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis

   The Journal of Neuroscience 17:6142–6151.

   https://doi.org/10.1523/JNEUROSCI.17-16-06142.1997

   • PubMed
   • Google Scholar
8. 1. Cataldo AM
   2. Peterhoff CM
   3. Troncoso JC
   4. Gomez-Isla T
   5. Hyman BT
   6. Nixon RA

   (2000) Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer’s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations

   The American Journal of Pathology 157:277–286.

   https://doi.org/10.1016/s0002-9440(10)64538-5

   • PubMed
   • Google Scholar
9. 1. Cataldo AM
   2. Petanceska S
   3. Terio NB
   4. Peterhoff CM
   5. Durham R
   6. Mercken M
   7. Mehta PD
   8. Buxbaum J
   9. Haroutunian V
   10. Nixon RA

   (2004) Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome

   Neurobiology of Aging 25:1263–1272.

   https://doi.org/10.1016/j.neurobiolaging.2004.02.027

   • PubMed
   • Google Scholar
10. 1. Chai Y
    2. Koppenhafer SL
    3. Shoesmith SJ
    4. Perez MK
    5. Paulson HL

    (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro

    Human Molecular Genetics 8:673–682.

    https://doi.org/10.1093/hmg/8.4.673

    • PubMed
    • Google Scholar
11. 1. Chang HHV
    2. Cook AA
    3. Watt AJ
    4. Cullen KE

    (2022) Loss of Flocculus Purkinje Cell firing precision leads to impaired Gaze Stabilization in a Mouse Model of Spinocerebellar Ataxia Type 6 (SCA6)

    Cells 11:2739.

    https://doi.org/10.3390/cells11172739

    • PubMed
    • Google Scholar
12. 1. Chazotte B

    (2011) Labeling lysosomes in live cells with LysoTracker

    Cold Spring Harbor Protocols 2011:5571.

    https://doi.org/10.1101/pdb.prot5571

    • PubMed
    • Google Scholar
13. 1. Chen CS
    2. Chen WN
    3. Zhou M
    4. Arttamangkul S
    5. Haugland RP

    (2000) Probing the cathepsin D using A BODIPY FL-pepstatin A: applications in fluorescence polarization and microscopy

    Journal of Biochemical and Biophysical Methods 42:137–151.

    https://doi.org/10.1016/s0165-022x(00)00048-8

    • PubMed
    • Google Scholar
14. 1. Chen J
    2. Chua KW
    3. Chua CC
    4. Yu H
    5. Pei A
    6. Chua BHL
    7. Hamdy RC
    8. Xu X
    9. Liu CF

    (2011) Antioxidant activity of 7,8-dihydroxyflavone provides neuroprotection against glutamate-induced toxicity

    Neuroscience Letters 499:181–185.

    https://doi.org/10.1016/j.neulet.2011.05.054

    • PubMed
    • Google Scholar
15. 1. Cheng PL
    2. Song AH
    3. Wong YH
    4. Wang S
    5. Zhang X
    6. Poo MM

    (2011) Self-amplifying autocrine actions of BDNF in axon development

    PNAS 108:18430–18435.

    https://doi.org/10.1073/pnas.1115907108

    • PubMed
    • Google Scholar
16. 1. Cheng XT
    2. Xie YX
    3. Zhou B
    4. Huang N
    5. Farfel-Becker T
    6. Sheng ZH

    (2018) Revisiting LAMP1 as a marker for degradative autophagy-lysosomal organelles in the nervous system

    Autophagy 14:1472–1474.

    https://doi.org/10.1080/15548627.2018.1482147

    • PubMed
    • Google Scholar
17. 1. Cook AA
    2. Jayabal S
    3. Sheng J
    4. Fields E
    5. Leung TCS
    6. Quilez S
    7. McNicholas E
    8. Lau L
    9. Huang S
    10. Watt AJ

    (2022) Activation of TrkB-Akt signaling rescues deficits in a mouse model of SCA6

    Science Advances 8:eabh3260.

    https://doi.org/10.1126/sciadv.abh3260

    • PubMed
    • Google Scholar
18. 1. Cortes CJ
    2. La Spada AR

    (2015) Autophagy in polyglutamine disease: Imposing order on disorder or contributing to the chaos?

    Molecular and Cellular Neurosciences 66:53–61.

    https://doi.org/10.1016/j.mcn.2015.03.010

    • PubMed
    • Google Scholar
19. 1. de Duve C

    (2005) The lysosome turns fifty

    Nature Cell Biology 7:847–849.

    https://doi.org/10.1038/ncb0905-847

    • PubMed
    • Google Scholar
20. 1. Du X
    2. Wang J
    3. Zhu H
    4. Rinaldo L
    5. Lamar KM
    6. Palmenberg AC
    7. Hansel C
    8. Gomez CM

    (2013) Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6

    Cell 154:118–133.

    https://doi.org/10.1016/j.cell.2013.05.059

    • PubMed
    • Google Scholar
21. 1. Du X
    2. Wei C
    3. Hejazi Pastor DP
    4. Rao ER
    5. Li Y
    6. Grasselli G
    7. Godfrey J
    8. Palmenberg AC
    9. Andrade J
    10. Hansel C
    11. Gomez CM

    (2019) α1ACT Is essential for survival and early cerebellar programming in a Critical Neonatal Window

    Neuron 102:770–785.

    https://doi.org/10.1016/j.neuron.2019.02.036

    • PubMed
    • Google Scholar
22. 1. Evans SF
    2. Irmady K
    3. Ostrow K
    4. Kim T
    5. Nykjaer A
    6. Saftig P
    7. Blobel C
    8. Hempstead BL

    (2011) Neuronal brain-derived neurotrophic factor is synthesized in excess, with levels regulated by sortilin-mediated trafficking and lysosomal degradation

    The Journal of Biological Chemistry 286:29556–29567.

    https://doi.org/10.1074/jbc.M111.219675

    • PubMed
    • Google Scholar
23. 1. Gao L
    2. Tian M
    3. Zhao HY
    4. Xu QQ
    5. Huang YM
    6. Si QC
    7. Tian Q
    8. Wu QM
    9. Hu XM
    10. Sun LB
    11. McClintock SM
    12. Zeng Y

    (2016) TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer’s disease

    Journal of Neurochemistry 136:620–636.

    https://doi.org/10.1111/jnc.13432

    • PubMed
    • Google Scholar
24. 1. Haapasalo A
    2. Sipola I
    3. Larsson K
    4. Akerman KEO
    5. Stoilov P
    6. Stamm S
    7. Wong G
    8. Castren E

    (2002) Regulation of TRKB surface expression by brain-derived neurotrophic factor and truncated TRKB isoforms

    The Journal of Biological Chemistry 277:43160–43167.

    https://doi.org/10.1074/jbc.M205202200

    • PubMed
    • Google Scholar
25. 1. Han X
    2. Zhu S
    3. Wang B
    4. Chen L
    5. Li R
    6. Yao W
    7. Qu Z

    (2014) Antioxidant action of 7,8-dihydroxyflavone protects PC12 cells against 6-hydroxydopamine-induced cytotoxicity

    Neurochemistry International 64:18–23.

    https://doi.org/10.1016/j.neuint.2013.10.018

    • PubMed
    • Google Scholar
26. 1. Hu YB
    2. Dammer EB
    3. Ren RJ
    4. Wang G

    (2015) The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration

    Translational Neurodegeneration 4:18.

    https://doi.org/10.1186/s40035-015-0041-1

    • PubMed
    • Google Scholar
27. 1. Huotari J
    2. Helenius A

    (2011) Endosome maturation

    The EMBO Journal 30:3481–3500.

    https://doi.org/10.1038/emboj.2011.286

    • PubMed
    • Google Scholar
28. 1. Jayabal S
    2. Ljungberg L
    3. Erwes T
    4. Cormier A
    5. Quilez S
    6. El Jaouhari S
    7. Watt AJ

    (2015) Rapid onset of motor deficits in a Mouse Model of Spinocerebellar Ataxia Type 6 Precedes Late Cerebellar Degeneration

    eNeuro 2:ENEURO.0094-15.2015.

    https://doi.org/10.1523/ENEURO.0094-15.2015

    • PubMed
    • Google Scholar
29. 1. Jayabal S
    2. Chang HHV
    3. Cullen KE
    4. Watt AJ

    (2016) 4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6

    Scientific Reports 6:29489.

    https://doi.org/10.1038/srep29489

    • PubMed
    • Google Scholar
30. 1. Jin LW
    2. Shie FS
    3. Maezawa I
    4. Vincent I
    5. Bird T

    (2004) Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities

    The American Journal of Pathology 164:975–985.

    https://doi.org/10.1016/s0002-9440(10)63185-9

    • PubMed
    • Google Scholar
31. 1. Johnson RA
    2. Lam M
    3. Punzo AM
    4. Li H
    5. Lin BR
    6. Ye K
    7. Mitchell GS
    8. Chang Q

    (2012) 7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome

    Journal of Applied Physiology 112:704–710.

    https://doi.org/10.1152/japplphysiol.01361.2011

    • PubMed
    • Google Scholar
32. 1. Kaur G
    2. Tan LX
    3. Rathnasamy G
    4. La Cunza N
    5. Germer CJ
    6. Toops KA
    7. Fernandes M
    8. Blenkinsop TA
    9. Lakkaraju A

    (2018) Aberrant early endosome biogenesis mediates complement activation in the retinal pigment epithelium in models of macular degeneration

    PNAS 115:9014–9019.

    https://doi.org/10.1073/pnas.1805039115

    • PubMed
    • Google Scholar
33. 1. Kim D
    2. Paggi JM
    3. Park C
    4. Bennett C
    5. Salzberg SL

    (2019) Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype

    Nature Biotechnology 37:907–915.

    https://doi.org/10.1038/s41587-019-0201-4

    • PubMed
    • Google Scholar
34. 1. Kim S
    2. Ochoa K
    3. Melli SE
    4. Yousufzai FAK
    5. Barrera ZD
    6. Williams AA
    7. McIntyre G
    8. Delgado E
    9. Bolish JN
    10. Macleod CM
    11. Boghos M
    12. Lens HP
    13. Ramos AG
    14. Wilson VB
    15. Maloney K
    16. Padron ZM
    17. Khan AH
    18. Blanco RE
    19. Soto I

    (2023) Disruptive lysosomal-metabolic signaling and neurodevelopmental deficits that precede Purkinje cell loss in a mouse model of Niemann-Pick Type-C disease

    Scientific Reports 13:5665.

    https://doi.org/10.1038/s41598-023-32971-0

    • PubMed
    • Google Scholar
35. 1. Klionsky DJ

    (2005) Autophagy

    Current Biology 15:R282–R283.

    https://doi.org/10.1016/j.cub.2005.04.013

    • PubMed
    • Google Scholar
36. 1. Koppel I
    2. Aid-Pavlidis T
    3. Jaanson K
    4. Sepp M
    5. Pruunsild P
    6. Palm K
    7. Timmusk T

    (2009) Tissue-specific and neural activity-regulated expression of human BDNF gene in BAC transgenic mice

    BMC Neuroscience 10:68.

    https://doi.org/10.1186/1471-2202-10-68

    • PubMed
    • Google Scholar
37. 1. Lawrence RE
    2. Zoncu R

    (2019) The lysosome as a cellular centre for signalling, metabolism and quality control

    Nature Cell Biology 21:133–142.

    https://doi.org/10.1038/s41556-018-0244-7

    • PubMed
    • Google Scholar
38. 1. Liu X
    2. Qi Q
    3. Xiao G
    4. Li J
    5. Luo HR
    6. Ye K

    (2013) O-methylated metabolite of 7,8-dihydroxyflavone activates TrkB receptor and displays antidepressant activity

    Pharmacology 91:185–200.

    https://doi.org/10.1159/000346920

    • PubMed
    • Google Scholar
39. 1. Liu C
    2. Chan CB
    3. Ye K

    (2016) 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders

    Translational Neurodegeneration 5:2.

    https://doi.org/10.1186/s40035-015-0048-7

    • PubMed
    • Google Scholar
40. 1. Love MI
    2. Huber W
    3. Anders S

    (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

    Genome Biology 15:550.

    https://doi.org/10.1186/s13059-014-0550-8

    • PubMed
    • Google Scholar
41. 1. Ludwig T
    2. Griffiths G
    3. Hoflack B

    (1991) Distribution of newly synthesized lysosomal enzymes in the endocytic pathway of normal rat kidney cells

    The Journal of Cell Biology 115:1561–1572.

    https://doi.org/10.1083/jcb.115.6.1561

    • PubMed
    • Google Scholar
42. 1. Mahapatra KK
    2. Panigrahi DP
    3. Praharaj PP
    4. Bhol CS
    5. Patra S
    6. Mishra SR
    7. Behera BP
    8. Bhutia SK

    (2019) Molecular interplay of autophagy and endocytosis in human health and diseases

    Biological Reviews of the Cambridge Philosophical Society 94:1576–1590.

    https://doi.org/10.1111/brv.12515

    • PubMed
    • Google Scholar
43. 1. Majzoub RN
    2. Wonder E
    3. Ewert KK
    4. Kotamraju VR
    5. Teesalu T
    6. Safinya CR

    (2016) Rab11 and Lysotracker Markers Reveal Correlation between Endosomal Pathways and Transfection Efficiency of Surface-Functionalized Cationic Liposome-DNA Nanoparticles

    The Journal of Physical Chemistry. B 120:6439–6453.

    https://doi.org/10.1021/acs.jpcb.6b04441

    • PubMed
    • Google Scholar
44. 1. Mannan AU
    2. Roussa E
    3. Kraus C
    4. Rickmann M
    5. Maenner J
    6. Nayernia K
    7. Krieglstein K
    8. Reis A
    9. Engel W

    (2004) Mutation in the gene encoding lysosomal acid phosphatase (Acp2) causes cerebellum and skin malformation in mouse

    Neurogenetics 5:229–238.

    https://doi.org/10.1007/s10048-004-0197-9

    • PubMed
    • Google Scholar
45. 1. Mellesmoen A
    2. Sheeler C
    3. Ferro A
    4. Rainwater O
    5. Cvetanovic M

    (2018) Brain Derived Neurotrophic Factor (BDNF) Delays Onset of Pathogenesis in Transgenic Mouse Model of Spinocerebellar Ataxia Type 1 (SCA1)

    Frontiers in Cellular Neuroscience 12:509.

    https://doi.org/10.3389/fncel.2018.00509

    • PubMed
    • Google Scholar
46. 1. Moya-Alvarado G
    2. Gonzalez A
    3. Stuardo N
    4. Bronfman FC

    (2018) Brain-Derived Neurotrophic Factor (BDNF) Regulates Rab5-Positive Early Endosomes in Hippocampal Neurons to Induce Dendritic Branching

    Frontiers in Cellular Neuroscience 12:493.

    https://doi.org/10.3389/fncel.2018.00493

    • PubMed
    • Google Scholar
47. 1. Moya-Alvarado G
    2. Tiburcio-Felix R
    3. Ibáñez MR
    4. Aguirre-Soto AA
    5. Guerra MV
    6. Wu C
    7. Mobley WC
    8. Perlson E
    9. Bronfman FC

    (2023) BDNF/TrkB signaling endosomes in axons coordinate CREB/mTOR activation and protein synthesis in the cell body to induce dendritic growth in cortical neurons

    eLife 12:e77455.

    https://doi.org/10.7554/eLife.77455

    • PubMed
    • Google Scholar
48. 1. O’Sullivan MJ
    2. Lindsay AJ

    (2020) The Endosomal Recycling Pathway-At the Crossroads of the Cell

    International Journal of Molecular Sciences 21:6074.

    https://doi.org/10.3390/ijms21176074

    • PubMed
    • Google Scholar
49. 1. Park HY
    2. Kim GY
    3. Hyun JW
    4. Hwang HJ
    5. Kim ND
    6. Kim BW
    7. Choi YH

    (2012) 7,8-Dihydroxyflavone exhibits anti-inflammatory properties by downregulating the NF-κB and MAPK signaling pathways in lipopolysaccharide-treated RAW264.7 cells

    International Journal of Molecular Medicine 29:1146–1152.

    https://doi.org/10.3892/ijmm.2012.935

    • PubMed
    • Google Scholar
50. 1. Parrini M
    2. Ghezzi D
    3. Deidda G
    4. Medrihan L
    5. Castroflorio E
    6. Alberti M
    7. Baldelli P
    8. Cancedda L
    9. Contestabile A

    (2017) Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome

    Scientific Reports 7:16825.

    https://doi.org/10.1038/s41598-017-17201-8

    • PubMed
    • Google Scholar
51. 1. Pescosolido MF
    2. Ouyang Q
    3. Liu JS
    4. Morrow EM

    (2021) Loss of Christianson Syndrome Na⁺/H⁺ Exchanger 6 (NHE6) Causes Abnormal Endosome Maturation and Trafficking Underlying Lysosome Dysfunction in Neurons

    The Journal of Neuroscience 41:9235–9256.

    https://doi.org/10.1523/JNEUROSCI.1244-20.2021

    • PubMed
    • Google Scholar
52. 1. Prekeris R
    2. Klumperman J
    3. Chen YA
    4. Scheller RH

    (1998) Syntaxin 13 mediates cycling of plasma membrane proteins via tubulovesicular recycling endosomes

    The Journal of Cell Biology 143:957–971.

    https://doi.org/10.1083/jcb.143.4.957

    • PubMed
    • Google Scholar
53. 1. Raudvere U
    2. Kolberg L
    3. Kuzmin I
    4. Arak T
    5. Adler P
    6. Peterson H
    7. Vilo J

    (2019) g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)

    Nucleic Acids Research 47:W191–W198.

    https://doi.org/10.1093/nar/gkz369

    • PubMed
    • Google Scholar
54. 1. Rueden CT
    2. Schindelin J
    3. Hiner MC
    4. DeZonia BE
    5. Walter AE
    6. Arena ET
    7. Eliceiri KW

    (2017) ImageJ2: ImageJ for the next generation of scientific image data

    BMC Bioinformatics 18:529.

    https://doi.org/10.1186/s12859-017-1934-z

    • PubMed
    • Google Scholar
55. 1. Schindelin J
    2. Arganda-Carreras I
    3. Frise E
    4. Kaynig V
    5. Longair M
    6. Pietzsch T
    7. Preibisch S
    8. Rueden C
    9. Saalfeld S
    10. Schmid B
    11. Tinevez JY
    12. White DJ
    13. Hartenstein V
    14. Eliceiri K
    15. Tomancak P
    16. Cardona A

    (2012) Fiji: an open-source platform for biological-image analysis

    Nature Methods 9:676–682.

    https://doi.org/10.1038/nmeth.2019

    • PubMed
    • Google Scholar
56. 1. Scott-Solomon E
    2. Kuruvilla R

    (2018) Mechanisms of neurotrophin trafficking via Trk receptors

    Molecular and Cellular Neurosciences 91:25–33.

    https://doi.org/10.1016/j.mcn.2018.03.013

    • PubMed
    • Google Scholar
57. 1. Skjeldal FM
    2. Strunze S
    3. Bergeland T
    4. Walseng E
    5. Gregers TF
    6. Bakke O

    (2012) The fusion of early endosomes induces molecular-motor-driven tubule formation and fission

    Journal of Cell Science 125:1910–1919.

    https://doi.org/10.1242/jcs.092569

    • PubMed
    • Google Scholar
58. 1. Solodkin A
    2. Gomez CM

    (2012)

    Handbook of Clinical Neurology

    461–473, Spinocerebellar ataxia type 6, Handbook of Clinical Neurology, Elsevier, 10.1016/B978-0-444-51892-7.00029-2, 21827907.

    • Google Scholar
59. 1. Song JW
    2. Misgeld T
    3. Kang H
    4. Knecht S
    5. Lu J
    6. Cao Y
    7. Cotman SL
    8. Bishop DL
    9. Lichtman JW

    (2008) Lysosomal activity associated with developmental axon pruning

    The Journal of Neuroscience 28:8993–9001.

    https://doi.org/10.1523/JNEUROSCI.0720-08.2008

    • PubMed
    • Google Scholar
60. 1. Stenmark H

    (2009) Rab GTPases as coordinators of vesicle traffic

    Nature Reviews. Molecular Cell Biology 10:513–525.

    https://doi.org/10.1038/nrm2728

    • PubMed
    • Google Scholar
61. 1. Sterling FR
    2. D’Amico J
    3. Brumfield AM
    4. Huegel KL
    5. Vaughan PS
    6. Morris K
    7. Schwarz S
    8. Joyce MV
    9. Boggess B
    10. Champion MM
    11. Maciuba K
    12. Allen P
    13. Marasco E
    14. Koch G
    15. Gonzalez P
    16. Hodges S
    17. Leahy S
    18. Gerstbauer E
    19. Hinchcliffe EH
    20. Vaughan KT

    (2023) StARD9 is a novel lysosomal kinesin required for membrane tubulation, cholesterol transport and Purkinje cell survival

    Journal of Cell Science 136:jcs260662.

    https://doi.org/10.1242/jcs.260662

    • PubMed
    • Google Scholar
62. 1. Tate BA
    2. Mathews PM

    (2006) Targeting the role of the endosome in the pathophysiology of Alzheimer’s disease: a strategy for treatment

    Science of Aging Knowledge Environment 2006:re2.

    https://doi.org/10.1126/sageke.2006.10.re2

    • PubMed
    • Google Scholar
63. 1. Unno T
    2. Wakamori M
    3. Koike M
    4. Uchiyama Y
    5. Ishikawa K
    6. Kubota H
    7. Yoshida T
    8. Sasakawa H
    9. Peters C
    10. Mizusawa H
    11. Watase K

    (2012) Development of Purkinje cell degeneration in a knockin mouse model reveals lysosomal involvement in the pathogenesis of SCA6

    PNAS 109:17693–17698.

    https://doi.org/10.1073/pnas.1212786109

    • PubMed
    • Google Scholar
64. 1. Vanier MT

    (2010) Niemann-Pick disease type C

    Orphanet Journal of Rare Diseases 5:16.

    https://doi.org/10.1186/1750-1172-5-16

    • PubMed
    • Google Scholar
65. 1. Vidyadhara DJ
    2. Lee JE
    3. Chandra SS

    (2019) Role of the endolysosomal system in Parkinson’s disease

    Journal of Neurochemistry 150:487–506.

    https://doi.org/10.1111/jnc.14820

    • PubMed
    • Google Scholar
66. 1. Vitelli R
    2. Santillo M
    3. Lattero D
    4. Chiariello M
    5. Bifulco M
    6. Bruni CB
    7. Bucci C

    (1997) Role of the small GTPase Rab7 in the late endocytic pathway

    The Journal of Biological Chemistry 272:4391–4397.

    https://doi.org/10.1074/jbc.272.7.4391

    • PubMed
    • Google Scholar
67. 1. Vivacqua G
    2. Renzi A
    3. Carpino G
    4. Franchitto A
    5. Gaudio E

    (2014)

    Expression of brain derivated neurotrophic factor and of its receptors: TrKB and p75NT in normal and bile duct ligated rat liver

    Italian Journal of Anatomy and Embryology = Archivio Italiano Di Anatomia Ed Embriologia 119:111–129.

    • PubMed
    • Google Scholar
68. 1. Watase K
    2. Barrett CF
    3. Miyazaki T
    4. Ishiguro T
    5. Ishikawa K
    6. Hu Y
    7. Unno T
    8. Sun Y
    9. Kasai S
    10. Watanabe M
    11. Gomez CM
    12. Mizusawa H
    13. Tsien RW
    14. Zoghbi HY

    (2008) Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels

    PNAS 105:11987–11992.

    https://doi.org/10.1073/pnas.0804350105

    • PubMed
    • Google Scholar
69. 1. Yamashita N
    2. Kuruvilla R

    (2016) Neurotrophin signaling endosomes: biogenesis, regulation, and functions

    Current Opinion in Neurobiology 39:139–145.

    https://doi.org/10.1016/j.conb.2016.06.004

    • PubMed
    • Google Scholar
70. 1. Zaidi N
    2. Maurer A
    3. Nieke S
    4. Kalbacher H

    (2008) Cathepsin D: a cellular roadmap

    Biochemical and Biophysical Research Communications 376:5–9.

    https://doi.org/10.1016/j.bbrc.2008.08.099

    • PubMed
    • Google Scholar
71. 1. Zhang Z
    2. Liu X
    3. Schroeder JP
    4. Chan CB
    5. Song M
    6. Yu SP
    7. Weinshenker D
    8. Ye K

    (2014) 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer’s disease

    Neuropsychopharmacology 39:638–650.

    https://doi.org/10.1038/npp.2013.243

    • PubMed
    • Google Scholar
72. 1. Zhu F
    2. Miao Y
    3. Cheng M
    4. Ye X
    5. Chen A
    6. Zheng G
    7. Tian X

    (2022) The CACNA1A Mutant Disrupts Lysosome Calcium Homeostasis in Cerebellar Neurons and the Resulting Endo-Lysosomal Fusion Defect Can be Improved by Calcium Modulation

    Neurochemical Research 47:249–263.

    https://doi.org/10.1007/s11064-021-03438-3

    • PubMed
    • Google Scholar
73. 1. Zhuchenko O
    2. Bailey J
    3. Bonnen P
    4. Ashizawa T
    5. Stockton DW
    6. Amos C
    7. Dobyns WB
    8. Subramony SH
    9. Zoghbi HY
    10. Lee CC

    (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel

    Nature Genetics 15:62–69.

    https://doi.org/10.1038/ng0197-62

    • PubMed
    • Google Scholar

Author details

1. Anna A Cook

   Biology Department, McGill University, Montreal, Canada

   Contribution

   Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-7654-0212

2. Tsz Chui Sophia Leung

   Biology Department, McGill University, Montreal, Canada

   Contribution

   Conceptualization, Data curation, Software, Investigation, Visualization, Methodology, Writing – review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0003-2158-4300

3. Max Rice

   1. Biology Department, McGill University, Montreal, Canada
   2. Department of Biological Sciences, Columbia University, New York, United States

   Contribution

   Formal analysis, Investigation, Methodology, Writing – review and editing

   Competing interests

   No competing interests declared

4. Maya Nachman

   Biology Department, McGill University, Montreal, Canada

   Contribution

   Data curation, Investigation, Methodology, Writing – review and editing

   Competing interests

   No competing interests declared

5. Élyse Zadigue-Dube

   Biology Department, McGill University, Montreal, Canada

   Contribution

   Data curation, Formal analysis, Investigation, Methodology, Writing – review and editing

   Competing interests

   No competing interests declared

6. Alanna Jean Watt

   Biology Department, McGill University, Montreal, Canada

   Contribution

   Conceptualization, Supervision, Funding acquisition, Visualization, Writing – original draft, Project administration, Writing – review and editing

   For correspondence

   alanna.watt@mcgill.ca

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-6371-6220

• 1,057

  views

• 59

  downloads

• 2

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.